Mild deficits in mice lacking pituitary adenylate cyclase-activating polypeptide receptor type 1 (PAC1) performing on memory tasks

Molecular Brain Research

Volumn 84, Issue 1-2, 2000, Pages 79-89

  Sauvage, Magdalena ^a   Brabet, Philippe ^b   Holsboer, Florian ^a   Bockaert, Joel ^b   Steckler, Thomas ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b CNRS   (France)

Author keywords

Knock out; Learning; Memory; Mutant; PAC1; PACAP; PACAP type 1 receptor; Pituitary adenylate cyclase activating polypeptide

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; RECEPTOR SUBTYPE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; KNOCKOUT MOUSE; LEARNING DISORDER; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SPATIAL DISCRIMINATION; TASK PERFORMANCE;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); CUES; DISCRIMINATION LEARNING; ELECTROSHOCK; FEAR; GENE DELETION; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MAZE LEARNING; MEMORY; MICE; MICE, KNOCKOUT; NEUROPSYCHOLOGICAL TESTS; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; RECEPTORS, PITUITARY HORMONE; SPACE PERCEPTION; SWIMMING;

ANIMALIA;

EID: 0034624224     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(00)00219-9     Document Type: Article

References (47)

1. Pituitary adenylate cylcase activating polypeptide (PACAP): Discovery and current status of research
2. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine and nervous systems
3. Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptor: Neuroendocrine and endocrine interaction
4. Excitotoxic hippocampal lesions disrupt allocentric spatial learning in mice: Effects of strain and task demands
5. Circadian changes in PACAP type 1 (PAC1) receptor mRNA in the rat suprachiasmatic and supraoptic nuclei
6. Anorectic and neurochemical effects of pituitary adenylate cyclase-activating polypeptide in rats
7. 2+ concentration in hippocampal neurons
8. Type I receptors for PACAP (a neuropeptide even more importance than VIP?)
9. Developmental expression of an amn(+) transgene rescues the mutant memory defect in amnesiac adults
10. The basal forebrain-cortical cholinergic system: Interpreting the functional consequences of excitotoxic lesions
11. Extinction of fear-potentiated startle: Blockade by infusion of an excitatory amino acid antagonist into the amygdala
12. A neuropeptide gene defined by the drosophila memory mutant amnesiac
13. Lesions of the medial or lateral perforant path have different effects on hippocampal contributions to place learning and on fear conditioning to context
14. The dorsal hippocampus is essential for context discrimination but not for context conditioning
15. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus
16. Pituitary adenylate cyclase-activating peptide (PACAP) in the retinohypothalamic tract: A potential daytime regulator of the biological clock
17. PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose intolerance
18. The PACAP receptor: Generation by alternative splicing of functional diversity among G protein-coupled receptors in nerve cells
19. Comparative distribution of immunoreactive pituitary adenylate cylcase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain
20. Differential alteration of hippocampal synaptic strength induced by pituitary adenylate cyclase activating polypeptide-38 (PACAP-38)
21. Axon terminals containing PACAP- and VIP-immunoreactivity form synapses with CRF-immunoreactive neurons in the dorsolateral division of the bed nucleus of the stria terminalis in the rat
22. Emotional memory systems of the brain
23. Pituitary adenylate cyclase-activating polypeptide-nerve terminals densely innervate corticotropin-releasing hormone-neurons in the hypothalamic paraventricular nucleus of the rat
24. PACAP promotes the survival of basal forebrain cholinergic neurons in vitro and in vivo; Comparison with effects of nerve growth factor
25. Effects of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) on the spontaneous release of acetylcholine from the rat hippocampus by brain microdialysis
26. Effects of intracerebroventricular administration of pituitary adenylate cyclase-activating polypeptide (PACAP) on the motor activity and reserpine-induced hypothermia in murines
27. Isolation of a novel 38-residue hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells
28. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP 38)
29. Anorectic effect of pituitary adenylate cyclase activating polypeptide (PACAP) in rats: Lack of evidence for involvement of hypothalamic neuropeptide gene expression
30. Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis
31. Presynaptic localization of PACAP-type I-receptor in hippocampal and cerebellar mossy fibres
32. Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation
33. Lesions of the fornix but not entorhinal or perirhinal cortex interfere with contextual fear conditioning
34. Distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) immunoreactivity in the hypothalamus and extended amygdala of the rat
35. Synaptic plasticity in the basolateral amygdala in transgenic mice expressing dominant-negative cAMP response element-binding protein (CREB) in forebrain
36. Receptors for pituitary adenylate cyclase-activating peptides in human pituitary adenomas
37. Cognitive enhancers in theory and practice: Studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease
38. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment
39. Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains
40. Expression of PACAP, and PACAP type 1 (PAC1) receptor mrna during development of the mouse embryo
41. Distribution of pituitary adenylate cyclase activating polypeptide mRNA in the developing rat brain
42. Differential signal transduction by five splice variants of the PACAP receptor
43. The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour
44. Vasoactive intestinal peptide (VIP) causes memory impairment in passive avoidance responding of the rat
45. Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptor in the rat brain
46. Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide increase cytosolic free calcium concentration in cultured rat hippocampal neurons
47. The role of the rat hippocampal system in several effects of context in extinction